Literature DB >> 23333306

A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice.

Cristina Escribano-Díaz1, Alexandre Orthwein, Amélie Fradet-Turcotte, Mengtan Xing, Jordan T F Young, Ján Tkáč, Michael A Cook, Adam P Rosebrock, Meagan Munro, Marella D Canny, Dongyi Xu, Daniel Durocher.   

Abstract

DNA double-strand break (DSB) repair pathway choice is governed by the opposing activities of 53BP1 and BRCA1. 53BP1 stimulates nonhomologous end joining (NHEJ), whereas BRCA1 promotes end resection and homologous recombination (HR). Here we show that 53BP1 is an inhibitor of BRCA1 accumulation at DSB sites, specifically in the G1 phase of the cell cycle. ATM-dependent phosphorylation of 53BP1 physically recruits RIF1 to DSB sites, and we identify RIF1 as the critical effector of 53BP1 during DSB repair. Remarkably, RIF1 accumulation at DSB sites is strongly antagonized by BRCA1 and its interacting partner CtIP. Lastly, we show that depletion of RIF1 is able to restore end resection and RAD51 loading in BRCA1-depleted cells. This work therefore identifies a cell cycle-regulated circuit, underpinned by RIF1 and BRCA1, that governs DSB repair pathway choice to ensure that NHEJ dominates in G1 and HR is favored from S phase onward.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333306     DOI: 10.1016/j.molcel.2013.01.001

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  444 in total

1.  A BRCA1-interacting lncRNA regulates homologous recombination.

Authors:  Vivek Sharma; Simran Khurana; Nard Kubben; Kotb Abdelmohsen; Philipp Oberdoerffer; Myriam Gorospe; Tom Misteli
Journal:  EMBO Rep       Date:  2015-09-27       Impact factor: 8.807

Review 2.  Non-homologous DNA end joining and alternative pathways to double-strand break repair.

Authors:  Howard H Y Chang; Nicholas R Pannunzio; Noritaka Adachi; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-17       Impact factor: 94.444

Review 3.  Double-strand break repair: 53BP1 comes into focus.

Authors:  Stephanie Panier; Simon J Boulton
Journal:  Nat Rev Mol Cell Biol       Date:  2013-12-11       Impact factor: 94.444

Review 4.  Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice.

Authors:  Arun Gupta; Clayton R Hunt; Sharmistha Chakraborty; Raj K Pandita; John Yordy; Deepti B Ramnarain; Nobuo Horikoshi; Tej K Pandita
Journal:  Radiat Res       Date:  2013-12-09       Impact factor: 2.841

Review 5.  Non-homologous end joining: emerging themes and unanswered questions.

Authors:  Sarvan Kumar Radhakrishnan; Nicholas Jette; Susan P Lees-Miller
Journal:  DNA Repair (Amst)       Date:  2014-02-26

6.  Isolation of chromatin from dysfunctional telomeres reveals an important role for Ring1b in NHEJ-mediated chromosome fusions.

Authors:  Cristina Bartocci; Jolene K Diedrich; Iliana Ouzounov; Julia Li; Andrea Piunti; Diego Pasini; John R Yates; Eros Lazzerini Denchi
Journal:  Cell Rep       Date:  2014-05-09       Impact factor: 9.423

7.  CtIP mediates replication fork recovery in a FANCD2-regulated manner.

Authors:  Jung Eun Yeo; Eu Han Lee; Eric A Hendrickson; Alexandra Sobeck
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

8.  Rif1 phosphorylation site analysis in telomere length regulation and the response to damaged telomeres.

Authors:  Jinyu Wang; Haitao Zhang; Mohammed Al Shibar; Belinda Willard; Alo Ray; Kurt W Runge
Journal:  DNA Repair (Amst)       Date:  2018-03-07

9.  Differences in 53BP1 and BRCA1 regulation between cycling and non-cycling cells.

Authors:  Monica Croke; Martin A Neumann; David A Grotsky; Ray Kreienkamp; Sree C Yaddanapudi; Susana Gonzalo
Journal:  Cell Cycle       Date:  2013-10-02       Impact factor: 4.534

Review 10.  53BP1: pro choice in DNA repair.

Authors:  Michal Zimmermann; Titia de Lange
Journal:  Trends Cell Biol       Date:  2013-10-04       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.